SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,855,224 | +272.6% | 16,200 | +348.4% | 0.07% | +233.3% |
| Q1 2023 | $497,979 | -89.9% | 3,613 | -90.5% | 0.02% | -91.9% |
| Q4 2022 | $4,910,434 | -29.5% | 37,895 | -39.8% | 0.26% | -4.8% |
| Q3 2022 | $6,964,000 | +49.1% | 63,000 | +1.1% | 0.27% | +35.1% |
| Q2 2022 | $4,670,000 | +926.4% | 62,297 | +1132.4% | 0.20% | +596.6% |
| Q4 2021 | $455,000 | -35.1% | 5,055 | -46.3% | 0.03% | -55.4% |
| Q1 2021 | $701,000 | +40.2% | 9,410 | +164.3% | 0.06% | -35.0% |
| Q3 2020 | $500,000 | – | 3,560 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |